Iveric Bio Inc reports results for the quarter ended in June - Earnings Summary

IVERIC bio

04/08/2021 15:23

* Iveric Bio Inc  ISEE.OQ  reported a quarterly adjusted loss
of 32 cents​​ per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 26
cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Iveric Bio Inc's reported EPS for the quarter was a loss of 32
cents​.
* The mean earnings estimate of analysts had fallen by
about 6.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Iveric Bio Inc shares had risen by 39.9% this quarter and
gained 27.8% so far this year.
* The company reported a quarterly loss of $30.14 million.
* Wall Street's median 12-month price target for Iveric Bio Inc
is $15.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 4 at 02:23 p.m.  ​All
figures in US dollars unless otherwise stated